Diagnostic gastroenterology

Consolidate Your Health Records with Therap's "Life Records for Families and Individuals" Electronic Health Record (EHR) System

Retrieved on: 
Tuesday, April 13, 2021
Medicine, Clinical medicine, Cancer screening, Colonoscopy, Diagnostic gastroenterology, Endoscopy, Large intestine, Electronic health records, Health

b"WATERBURY, Conn., April 13, 2021 /PRNewswire/ -- As medical practices, clinics, and hospitals become more specialized it can be difficult to see the same doctor on a regular basis and even harder to manage your medical records.

Key Points: 
  • b"WATERBURY, Conn., April 13, 2021 /PRNewswire/ -- As medical practices, clinics, and hospitals become more specialized it can be difficult to see the same doctor on a regular basis and even harder to manage your medical records.
  • A clinic may hand you a record of a colonoscopy, electrocardiogram, or lab work as you walk out the door but where do you keep it and how big a folder do you lug to your next appointment.
  • The power and sophistication of Therap's Industry leading EHR is now available and affordable for individuals and families to maintain your medical history and, if necessary, the medical histories of your family in an easily accessible web based EHR system.\nTherap began developing and marketing its EHR in 2003 for human services organizations.
  • Therap's system is web based, inexpensive, transparent, and full featured.

U.S. FDA Grants De Novo Clearance for First and Only Artificial Intelligence System for Colonoscopy; Medtronic Launches GI Genius™ Intelligent Endoscopy Module

Retrieved on: 
Monday, April 12, 2021
Clinical medicine, Medicine, Medical specialties, Large intestine, Diagnostic gastroenterology, Cancer screening, Gynaecology, Polyp, Colonoscopy, Artificial intelligence, Colorectal polyp

The GI Genius module is the first and only commercially available computer-aided detection (CADe) system using artificial intelligence (AI) to identify colorectal polyps.

Key Points: 
  • The GI Genius module is the first and only commercially available computer-aided detection (CADe) system using artificial intelligence (AI) to identify colorectal polyps.
  • With GI Genius we can tap into the potential of artificial intelligence approaches to increase detection rates.
  • "With FDA de novo clearance for the GI Genius and its AI capabilities, we expect to enhance and improve colonoscopies and polyp detection.
  • The GI Genius intelligent endoscopy module received de novo clearance from the U.S. FDA on April 9, 2021.

Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy

Retrieved on: 
Monday, April 12, 2021
Clinical medicine, Medicine, Medical specialties, Diagnostic gastroenterology, Endoscopy, Cancer screening, Large intestine, Colonoscopy, Colorectal cancer, Polyp

The device is the first of its kind to obtain the FDA approval through the De Novo application.

Key Points: 
  • The device is the first of its kind to obtain the FDA approval through the De Novo application.
  • ), where detection rates improved very significantly with GI Genius technology versus standard colonoscopy, regardless of skill level or endoscope used.
  • The first ever approval of an artificial intelligence device for lesion detection in colonoscopies further strengthens Cosmo\'s commitment to fight colorectal cancer.
  • We are extremely pleased and very optimistic about the impact the GI Genius intelligent endoscopy module will have on the US patient population undergoing colonoscopy.

Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy

Retrieved on: 
Monday, April 12, 2021
Clinical medicine, Medicine, Medical specialties, Diagnostic gastroenterology, Endoscopy, Cancer screening, Large intestine, Colonoscopy, Colorectal cancer, Polyp

The device is the first of its kind to obtain the FDA approval through the De Novo application.

Key Points: 
  • The device is the first of its kind to obtain the FDA approval through the De Novo application.
  • ), where detection rates improved very significantly with GI Genius technology versus standard colonoscopy, regardless of skill level or endoscope used.
  • The first ever approval of an artificial intelligence device for lesion detection in colonoscopies further strengthens Cosmo\'s commitment to fight colorectal cancer.
  • We are extremely pleased and very optimistic about the impact the GI Genius intelligent endoscopy module will have on the US patient population undergoing colonoscopy.

Worldwide Fecal Occult Testing Industry to 2026 - Players Include Abbott Laboratories, Beckman Coulter and Eiken Chemical Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 8, 2021
Health, Other Health, Diagnostic gastroenterology, Clinical medicine, Medicine, Stool tests, Medical specialties, Fecal occult blood, Occult blood, FOBT, Stool, Rectovaginal examination

The "Fecal Occult Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fecal Occult Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global fecal occult testing market grew at a CAGR of around 5% during 2015-2020.
  • Looking forward, the publisher expects the global fecal occult testing market to exhibit moderate growth during the next five years.
  • A fecal occult blood test (FOBT) is a noninvasive procedure used to detect hidden blood in the feces or stool.

Pristine Surgical and NexOptic Announce Commercial Agreement To Use AI for Single-Use Surgical Endoscopy Explains NexOptic Chairman Rich Geruson

Retrieved on: 
Wednesday, April 7, 2021
Endoscopy, Diagnostic gastroenterology, Light-emitting diode, Endoscope

Pristine Surgicals single-use endoscopes use high-performance digital image sensors, advanced high-brightness LEDs and powerful graphics-processing hardware and software to deliver high-definition, high-quality images in a single-use surgical endoscope at reduced cost.

Key Points: 
  • Pristine Surgicals single-use endoscopes use high-performance digital image sensors, advanced high-brightness LEDs and powerful graphics-processing hardware and software to deliver high-definition, high-quality images in a single-use surgical endoscope at reduced cost.
  • The companies will work together to incorporate NexOptics Aliis technology into Pristines single-use endoscopic visualization platform for image optimization.
  • Were excited to work with NexOptic to use theirALIIS platform to advance our deployment of artificial intelligence capabilities and help us further that mission.
  • Headquartered in Manchester, N.H., Pristine Surgical is led by an experienced management team, a seven-person board of managers and a 10-person medical advisory board.

Erbe Elektromedizin to acquire Maxer Endoscopy

Retrieved on: 
Tuesday, April 6, 2021
Biotechnology, Technology, Professional services, Health, General Health, Other Technology, Medical devices, Hospitals, Surgery, Audio, Video, Finance, Medicine, Clinical medicine, Medical specialties, Endoscopy, Diagnostic gastroenterology, Laparoscopy, Erbe, Arthroscopy, Maxer, Erbe

View the full release here: https://www.businesswire.com/news/home/20210406005418/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210406005418/en/
    From left to right: Christian O. Erbe, CEO Erbe Elektromedizin GmbH, Shirish Joshi, General Manager Maxer Endoscopy GmbH, Gayatri Joshi, Shareholder Maxer Endoscopy GmbH, Daniel Zimmermann, CFO Erbe Elektromedizin GmbH, and Marcus Felstead, CMO Erbe Elektromedizin GmbH.
  • Entering into the world of fluorescence imaging systems is the logical first step to provide the required added value to our customers", according to Christian O. Erbe, CEO & President at Erbe Elektromedizin GmbH.
  • Now, Erbe will be able to offer best-in-class performance with 4K and fluorescence-guided systems in endoscopy as well as for open surgeries.
  • Maxer manufactures a wide range of endoscopic systems and instruments for laparoscopy, hysteroscopy, urology, pediatric surgery, arthroscopy, spine endoscopy and ENT surgery.

PE GI Solutions and Ambulatory Center for Endoscopy, LLC Expand Their Existing Partnership in the Acquisition of Hudson Bergen Medical Center, LLC

Retrieved on: 
Wednesday, March 24, 2021
Diagnostic gastroenterology, Endoscopy, Ambu, Medicine, Academic journals, Health care

NORTH BERGEN, N.J., March 24, 2021 /PRNewswire/ -- PE GI Solutions and Ambulatory Center for Endoscopy, LLC (ACE) have acquired Hudson Bergen Medical Center, LLC.

Key Points: 
  • NORTH BERGEN, N.J., March 24, 2021 /PRNewswire/ -- PE GI Solutions and Ambulatory Center for Endoscopy, LLC (ACE) have acquired Hudson Bergen Medical Center, LLC.
  • The surgical center has officially become a second location for the existing Ambulatory Center for Endoscopy, LLC and has formally been renamed Hudson Bergen Endoscopy and Surgical Center, LLC.
  • "PE GI Solutions and Ambulatory Center for Endoscopy, LLC leveraged and expanded on our existing strategic partnership through this acquisition," says Larry Trenk, Vice President of Operations at PE GI Solutions.
  • For more information about the acquisition of Hudson Bergen Endoscopy and Surgical Center, LLC and PE GI Solution's development and management services, please visit the company's website here .

Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center

Retrieved on: 
Monday, March 15, 2021
Medical specialties, Medicine, Clinical medicine, Large intestine, Digestive system, Gastroenterology, Laxatives, Diagnostic gastroenterology, Enema, Colonoscopy, Colon cleansing

The colonoscopies will be performed using the Pure-Vu System after the patient has received minimal to no purgative preparation and two enemas.

Key Points: 
  • The colonoscopies will be performed using the Pure-Vu System after the patient has received minimal to no purgative preparation and two enemas.
  • Cleansing success will be attained if a Boston Bowel Preparation Scale (BBPS) of 2 is achieved in all three colonic segments.
  • The primary outcome of the study will be the proportion of patients who achieve an adequate bowel preparation to identify bleeding lesions in all three colonic segments.
  • Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.

Close Relationships with Companion Animals favoring adoption of Minimally Invasive Procedures to alleviate Post-Surgical Pain charts Growth in Veterinary Endoscopes Market, Market Projected to expand at a CAGR of 7.1% from 2019 - 2027: TMR

Retrieved on: 
Monday, March 15, 2021
Medicine, Endoscopy, Clinical medicine, Health sciences, Diagnostic gastroenterology, Veterinarian, Veterinary medicine, Endoscope

Gastrointestinal parasitism infections is a major problem in companion animals and livestock animals that causes oedema, diarrhea, pain, and even death.

Key Points: 
  • Gastrointestinal parasitism infections is a major problem in companion animals and livestock animals that causes oedema, diarrhea, pain, and even death.
  • Besides this, the pain factor of traditional veterinary medicine is resulting in rising acceptance of modern veterinary medicine, including veterinary endoscopy.
  • The increasing aid for veterinary endoscopy provided by governments in some emerging economies is indirectly creating opportunities in the veterinary endoscopes market.
  • Rising acceptance of minimally invasive endoscopic procedures for companion animals, especially for gastrointestinal problems spurring growth in veterinary endoscopes market.